SRZN Stock Analysis: Buy, Sell, or Hold?
SRZN - Surrozen, Inc. Common
$28.15
-1.72 (-5.76%)
▼
5d:
-2.8%
30d:
-7.16%
90d:
+14.99%
BUY
HIGH Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 08, 2026
0d
Get Alerted When SRZN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SRZN shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: SRZN shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: SRZN is currently trading at $28.15, which is considered oversold relative to its 30-day fair value range of $29.09 to $32.58.
Technical Outlook: Technically, SRZN is showing support break momentum. The price is currently testing key support at $27.53. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $42.50 (+51.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SRZN is showing support break momentum. The price is currently testing key support at $27.53. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $42.50 (+51.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$29.09 -
$32.58
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.8%)
- BULLISH: Trading 51.0% below Wall St target ($42.50)
Trading Range Analysis
30-Day Trading Range
$29.09 -
$32.58
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$27.53
Resistance Level
$35.00
Current Trend
Support Break
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.06
Wall Street Target
$42.50
(+51.0%)
Revenue Growth (YoY)
408.6%
Share & Embed Analysis
Last updated: May 18, 2026 8:33 AM ET
Data refreshes hourly during market hours. Next update: 9:33 AM
Data refreshes hourly during market hours. Next update: 9:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRZN showing a specific setup today?
Insider Activity (6 Months)
20
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Tcg Crossover Gp Ii, Llc
BUY
106658 shares
2026-03-24
Tcg Crossover Gp Ii, Llc
BUY
15223 shares
2026-03-23
Tcg Crossover Gp Ii, Llc
BUY
1190 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 55 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 63 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 55 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$203 | 52 HOLD |
